News
2021 Antimicrobial Resistance Benchmark report
The third AMR Benchmark is an independent report that compares and analyses how pharmaceutical companies are responding to the crisis of antimicrobial resistance.
Join the next GARDP AMR discussion 19th November
This World Antimicrobial awareness week, GARDP, together with WHO, will be holding an AMR Discussions webinar. A panel will discuss the roles that different actors can play in the development of new antibiotics.
Media-attention for AMR: “Create anti-bodies to strengthen bodies’ defences.”
For the Dutch radio program at NPO radio 1, Suzan Rooijakkers, explains how Antimicrobial Resistance (AMR) continues to threaten our abilities to treat common infections.
Horizon Europe launched with a budget of €95.5 billion
Horizon Europe, EU’s key funding programme for research and innovation, has just been launched with a budget of €95.5 billion.
G7 Health Ministers meet to discuss improved collaboration after COVID-19
The G7 group of nations met in the UK on June 11-13, and discussed on helping the world fight and then build back better from coronavirus and create a greener, more prosperous future.
2020 antibacterial agents in clinical and preclinical development: an overview and analysis
The World Health Organization’s (WHO) 2020 annual review of the clinical and preclinical antibacterial pipelines evaluates the potential of antibacterial candidates in different stages of development.